Irinotecan for Treatment of Childhood Cancers: A Promising Therapeutic Partner

E-ISSN： 1875-6301|6|4|283-293

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.6, Iss.4, 2010-11, pp. : 283-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liposomal Irinotecan in the Treatment of Refractory Pancreatic Cancer

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 4, 2016-11 ,pp. : 376-383

Bentham Science Publishers

Access to resources Recommend Favorite

Ovarian and Uterine Functions in Female Survivors of Childhood Cancers

The Oncologist, Vol. 23, Iss. 2, 2018-02 ,pp. : 214-224

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population mixing, childhood leukaemia, CNS tumours and other childhood cancers in Yorkshire

By Parslow R.C. Law G.R. Feltbower R. Kinsey S.E. McKinney P.A.

European Journal of Cancer, Vol. 38, Iss. 15, 2002-10 ,pp. : 2033-2040

Elsevier

Access to resources Recommend Favorite

Molecular Treatment of Different Breast Cancers

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 6, 2015-01 ,pp. : 701-720

Bentham Science Publishers

Access to resources Recommend Favorite

A general review of the role of irinotecan (CPT11) in the treatment of gastric cancer

Medical Oncology, Vol. 24, Iss. 2, 2007-06 ,pp. : 137-146

Humana Press, Inc

Access to resources Recommend Favorite